Valeant acquires Nicox's US subsidiary

Valeant acquires Nicox’s US subsidiary

Wednesday, November 19 2014 | 00 h 00 min | Acquisitions

Valeant acquires Nicox Inc., Nicox’s US subsidiary specialized in diagnostic tests.

The deal is worth up to US$20 million, with US$10 million to be paid out upfront.

Nicox will concentrate on ophthalmic therapeutics. It intends to build an international ophthalmic company in Europe and in the United States, in light of its acquisition of Aciex and positive phase 3 results for Vesneo® (latanoprostene bunod).

Expected to be launched in 2016, this glaucoma therapy is under license by the Valeant division Bausch + Lomb. Valeant estimates that the drug’s potential peak global sales will exceed CA$1 billion.

For further information: http://www.nicox.com/news-media/news/acquisition-nicoxs-us-ophthalmic-diagnostics-subsidiary-valeant-2/

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

EssilorLuxottica is taking part in the 2024 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Seattle, USA, where it will present new findings from its studies on advancements in myopia management with Essilor Stellest lenses..

Voila Optik March-April 2024 lool Altair

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

EssilorLuxottica to Release New Research Findings at ARVO, Including Five-year Clinical Findings of Essilor Stellest Lenses

Lool Eyewear Introduces New Collection for Deco Series

lool eyewear launches its SS24 collection, from the Deco Series. Inspired by art deco from minimalism, this collection expresses itself in noble metal finishes.

Learn More

Essilor Stellest Lenses Now Available in Sun Tints and an Extended Range

Essilor® Stellest™ lenses slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day.

WCO and CooperVision Partner on Myopia Management Navigator Educational Resource

Interactive Guide Aimed at Boosting Adoption of Myopia Management Global Standard of Care

New Research Report Highlights Actions to Attract Potential & Former Contact Lens Patients

Contact Lens Institute™ Data Illustrates Significant Upside Opportunity for Eye Care Practices and Pinpoints What Drives Consideration

Valeant acquires Nicox’s US subsidiary

Featured Posts